Edward M. Schaeffer

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

2022 · Research Square

<title>Abstract</title> Prostate cancer is the most frequent cancer in men and a leading cause of cancer death. Determining a patient’s optimal therapy is a challenge, where oncologists must select a therapy with the highest likelihood …

Using Attention-based Deep Learning to Predict ERG:TMPRSS2 Fusion Status in Prostate Cancer from Whole Slide Images

2022 · bioRxiv (Cold Spring Harbor Laboratory)

Abstract Prostate cancer (PCa) is associated with several genetic alterations which play an important role in the disease heterogeneity and clinical outcome including gene fusion between TMPRSS2 and members of the ETS family of transcription …